Tivozanib multi target TKI
systematic review meta-analysis network meta-analysis
 

     

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultdeath (overall survival) progression or death (progression free survival PFS)

renal-cell carcinoma (advanced)  

TIVO-1, 2013      NCTtivozanibsorafenibsuggesting25%-20%



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons